Delivery Order SPE2DB24D2205-SPE2DB26FDSHP
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,709.46 on August 12, 2025, for the supply of Dupixent 300 mg/2 mL pens. This is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,987.47 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitive award, issued under firm fixed pricing, represents a child contract to AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $110,776.11 for Dupixent 300 mg/2 mL pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded procurement supporting federal pharmaceutical supply needs. The contract will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $37,144.14 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens (2 mL units). This firm fixed-price delivery order, awarded on August 20, 2025, with a completion date of August 21, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,400.47 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,128.38 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's existing DLA contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the performing...
- The Defense Logistics Agency awarded a delivery order valued at $82,931.17 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on September 23, 2025, with completion scheduled for September 24, 2025. This competitively awarded, firm fixed-price delivery order represents a single-unit pharmaceutical supply transaction under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency (DLA) awarded a $21,260.48 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and represents a single shipment of the biologic medication to support federal medical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,298.32 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen (2 ml) on June 27, 2025, with an ultimate completion date of June 30, 2025. This competitive award (no set-aside used) carries firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $57,542.31 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA, leveraging the company's position as a critical healthcare solutions provider. The award is structured as a child...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB26FDSHPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $56,453.92 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on October 14, 2025, with completion targeted for October 15, 2025. This non-competitive, firm fixed-price delivery order represents a procurement of the specialty pharmaceutical product to support federal medical supply needs. The award was issued under a child contract mechanism, leveraging AmerisourceBergen's established relationship with DLA as a critical pharmaceutical distributor for military and federal healthcare systems. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the company to supply a wide range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's established federal procurement portfolio demonstrates consistent capability in fulfilling competitive pharmaceutical delivery requirements for the Defense Health Agency and other government healthcare systems, with the place of performance located in Conshohocken, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $56.5k | 10/14/25 |